Showing results (1031-1040 of 1,453) with videos related to

Sort By:
Pageof 146
Biorxiv : the Preprint Server for Biology|July 9, 2024
Increasing the representation of minoritized youth for inclusive and reproducible brain-behavior associationsJivesh Ramduny, Lucina Q Uddin, Tamara Vanderwal, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|December 9, 2023
What, how and when do families communicate about ALS? A qualitative exploration of parents' and children's perceptionsMarion Sommers-Spijkerman, Anna Stukker, Melinda S Kavanaugh, et al.
Public Health Reports (Washington, D.C. : 1974)|November 12, 2015
Policy, Systems, and Environmental Approaches to Obesity Prevention: Translating and Disseminating Evidence from PracticeJennifer Leeman, Nancy Aycock, Amy Paxton-Aiken, et al.
Journal of Critical Care|May 27, 2017
Body weight-supported bedside treadmill training facilitates ambulation in ICU patients: An interventional proof of concept studyJuultje Sommers, Denise C Wieferink, Dave A Dongelmans, et al.
International Journal of Radiation Oncology, Biology, Physics|June 1, 1988
Radiation therapy and conservation surgery for primary and recurrent carcinoma of the vulva: report of 40 patients and a review of the literatureW M Pao, C A Perez, R R Kuske, et al.
Cancer|March 1, 1988
Serum copper in ovarian carcinomaA J Jacobs, G M Sommers, J H Axelrod, et al.
Puerto Rico Health Sciences Journal|September 20, 2019
Comparison of Skin Biomechanics and Skin Color in Puerto Rican and Non-Puerto Rican WomenYadira Regueira, Jamison D Fargo, Deborah Tiller, et al.
Biological Psychology|May 15, 2012
Characterizing the anomalous cognition-emotion interactions in externalizingArielle R Baskin-Sommers, John J Curtin, Christine L Larson, et al.
Proceedings. AMIA Symposium|February 3, 1999
Clinical event management using push technology--implementation and evaluation at two health care centersH R Warner, S Miller, K Jennings, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1979
Fortimicin A: collaborative in vitro susceptibility. Comparison with amikacin and gentamicin against 11,840 clinical bacterial isolatesR N Jones, A L Barry, P C Fuchs, et al.
Pageof 146